Business Context and Reporting Period
This Form 8-K was filed by DarioHealth Corp. on May 21, 2019. The company is incorporated in Delaware and operates from Caesarea, Israel. The filing serves as a current report to disclose an investor presentation used in meetings regarding a proposed offering.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of an event rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing. The primary event is the distribution of an investor presentation (Exhibit 99.1) related to a proposed capital offering.
Guidance, Outlook, and Risks
- Proposed Offering: The company is conducting investor meetings regarding a proposed offering, though specific terms are not detailed in the 8-K text itself.
- Forward-Looking Statements: The company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation) for specific details on the proposed offering, as the 8-K only references its existence.
- Verify the current status of the proposed offering, as the filing does not confirm if the offering was completed or abandoned.
- Note the company's status as an emerging growth company, which may impact financial reporting requirements.
- Confirm the trading symbols: Common Stock (DRIO) and Warrants (DRIOW) on The Nasdaq Capital Market.